Published on in Vol 11 (2025)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/64663, first published .
Impact of Disclosing to Patients the Use of Antiretroviral Resistance Testing Results for Molecular HIV Surveillance: A Randomized Experiment in 2 National Surveys

Impact of Disclosing to Patients the Use of Antiretroviral Resistance Testing Results for Molecular HIV Surveillance: A Randomized Experiment in 2 National Surveys

Impact of Disclosing to Patients the Use of Antiretroviral Resistance Testing Results for Molecular HIV Surveillance: A Randomized Experiment in 2 National Surveys

Jeremy Sugarman   1, 2 * , MD, MPH, MA ;   Juli Bollinger   1 * , MS ;   Jose Agostini   3 , BSW ;   Kevin Weinfurt   4 , PhD ;   Gail Geller   1, 2 , MHS, ScD ;   Sheethal Jose   1, 5 , PhD ;   Marissa Hannah   3 , MPH ;   O. Winslow Edwards   3 , MPH ;   Leslie Meltzer Henry   1, 6 , JD, PhD ;   Travis Sanchez   3 , DVM, MPH

1 Berman Institute of Bioethics, Johns Hopkins University, Baltimore, MD, United States

2 School of Medicine, Johns Hopkins University, Baltimore, MD, United States

3 Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA, United States

4 Department of Population Health Sciences, Duke University School of Medicine, Durham, NC, United States

5 Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States

6 Carey School of Law, University of Maryland, Baltimore, MD, United States

*these authors contributed equally

Corresponding Author:

  • Jeremy Sugarman, MD, MPH, MA
  • Berman Institute of Bioethics
  • Johns Hopkins University
  • 1809 Ashland Avenue
  • Baltimore, MD 21205
  • United States
  • Phone: 1 410-614-5634
  • Email: jsugarman@jhu.edu